Regen BioPharma Inc (RGBP)

[cvinvestor]

Funding is the key issue left to resolve. RGBP has some good partnerships in place for pipeline discovery and advancement, but funding for all this is the great unknown. If Lander really is able to build "non-dilutive" financing through grants, licensing agreements or some type of revolving credit instead of insider share distribution, this could rise quickly. But until we get some solid and positive news on funding for the pipeline, we will have to wait for positive price movement.